Chemo Fog pp 19-20 | Cite as

Oncology Pharmacist’s Perspective

  • Rachel Clark-Vetri
Part of the Advances in Experimental Medicine and Biology book series (AEMB, volume 678)


The pharmacist’s role places them squarely on the front line of the benefit-risk analysis of drug administration. They are often the ones who explain the drugs to the patients and, in the process, supply part of the information about which patients must make an informed decision about their chemotherapy. This chapter presents the reflections of one oncology/pain specialty pharmacist.


Cognitive Impairment National Comprehensive Cancer Network Front Line Bone Marrow Suppression Refuse Treatment 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


  1. 1.
    NCCN (National Comprehensive Cancer Network) Clinical Practice Guidelines in Oncology™— (last accessed July 2, 2009).Google Scholar

Copyright information

© Landes Bioscience and Springer Science+Business Media 2010

Authors and Affiliations

  • Rachel Clark-Vetri
    • 1
  1. 1.Department of Pharmacy PracticeTemple University School of PharmacyPhiladelphiaUSA

Personalised recommendations